Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers
- Conditions
- Facial Wrinkles
- Interventions
- Device: hyaluronic acid dermal fillers
- Registration Number
- NCT01151436
- Lead Sponsor
- Galderma R&D
- Brief Summary
The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction linked to the global management of facial rejuvenation with a new range of hyaluronic acid dermal fillers.
- Detailed Description
The range of fillers tested in this study includes 5 different hyaluronic acid dermal fillers: Emervel Touch, Emervel Classic, Emervel Deep, Emervel Volume and Emervel Lips.
The study will last 6 month.
Injections will be performed at baseline. If necessary, the investigator will perform touch-up injections at the following visit (3 weeks later).
Investigator and subject satisfaction will be collected through questionnaires.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 77
- Seeking tissue augmentation treatment on the face,
- Presenting a score of 3 (Moderately deep wrinkle)or 4 (Deep wrinkle) on the Lemperle Rating Scale (LRS) of both nasolabial folds.
- At risk in term of precautions, warnings and contra-indication referred in the package insert of the study devices,
- Who underwent previous injection of permanent filler in the injected area.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description hyaluronic acid hyaluronic acid dermal fillers -
- Primary Outcome Measures
Name Time Method Full Face Global Aesthetic Improvement 6 months after last injection Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
1. improved
2. much improved
3. very much improved
- Secondary Outcome Measures
Name Time Method PERIORBITAL LINES SEVERITY ASSESSMENT 6 MONTHS AFTER LAST INJECTION Severity scored on Lemperle Rating Scale:
0: no wrinkles
1. just perceptible wrinkle
2. shallow wrinkle
3. moderately deep wrinkle
4. deep wrinkle, well-defined edges
5. very deep wrinkle redundant foldCHEEK FOLDS SEVERITY ASSESSMENT 6 MONTHS AFTER LAST INJECTION Severity scored on Lemperle Rating Scale:
0: no wrinkles
1. just perceptible wrinkle
2. shallow wrinkle
3. moderately deep wrinkle
4. deep wrinkle, well-defined edges
5. very deep wrinkle redundant foldNASOLABIAL FOLDS SEVERITY ASSESSMENT 6 months after last injection Severity scored on Lemperle Rating Scale:
0: no wrinkles
1. just perceptible wrinkle
2. shallow wrinkle
3. moderately deep wrinkle
4. deep wrinkle, well-defined edges
5. very deep wrinkle redundant foldUPPER LIP LINES SEVERITY ASSESSMENT 6 MONTHS AFTER LAST INJECTION Severity scored on Lemperle Rating Scale:
0: no wrinkles
1. just perceptible wrinkle
2. shallow wrinkle
3. moderately deep wrinkle
4. deep wrinkle, well-defined edges
5. very deep wrinkle redundant foldMARIONETTE LINES SEVERITY ASSESSMENT 6 MONTHS AFTER LAST INJECTION Severity scored on Lemperle Rating Scale:
0: no wrinkles
1. just perceptible wrinkle
2. shallow wrinkle
3. moderately deep wrinkle
4. deep wrinkle, well-defined edges
5. very deep wrinkle redundant foldLIP ENHANCEMENT ASSESSMENT 6 MONTHS AFTER LAST INJECTION Lip fullness grading scale score:
0: very thin lip
1. thin lip
2. moderately thick lip
3. thick lip
4. full lip
Trial Locations
- Locations (1)
Galderma investigational site
🇩🇪Darmstadt, Germany